Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 26-deoxy-actein
2. 27-deoxyactein
1. 27-deoxyactein
2. 264624-38-6
3. 2d5auv13ax
4. [(1r,1'r,3'r,4s,4'r,5r,5'r,6'r,10's,12's,13's,16'r,18's,21'r)-1,4',6',12',17',17'-hexamethyl-18'-[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxyspiro[3,6-dioxabicyclo[3.1.0]hexane-4,8'-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosane]-3'-yl] Acetate
5. Unii-2d5auv13ax
6. 26-deoxy-actein
7. 27-deoxyactein, Hplc Grade
8. Schembl564106
9. Chebi:70242
10. Gcmgjwlogksugx-rbkchlqlsa-
11. Dtxsid20181062
12. Hy-n6264
13. Mfcd07783721
14. Zinc96086358
15. Akos037514979
16. Beta-d-xylopyranoside, (3beta,12beta,16beta,23s,24r,25r)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl
17. Cs-0032801
18. J-016441
19. Q27138580
20. .beta.-d-xylopyranoside, (3.beta.,12.beta.,16.beta.,23s,24r,25r)-12-(acetyloxy)-16,23:23,26:24,25-triepoxy-9,19-cyclolanostan-3-yl
| Molecular Weight | 660.8 g/mol |
|---|---|
| Molecular Formula | C37H56O10 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 4 |
| Exact Mass | 660.38734798 g/mol |
| Monoisotopic Mass | 660.38734798 g/mol |
| Topological Polar Surface Area | 136 Ų |
| Heavy Atom Count | 47 |
| Formal Charge | 0 |
| Complexity | 1360 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 18 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A UNII-2D5AUV13AX manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of UNII-2D5AUV13AX, including repackagers and relabelers. The FDA regulates UNII-2D5AUV13AX manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. UNII-2D5AUV13AX API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A UNII-2D5AUV13AX supplier is an individual or a company that provides UNII-2D5AUV13AX active pharmaceutical ingredient (API) or UNII-2D5AUV13AX finished formulations upon request. The UNII-2D5AUV13AX suppliers may include UNII-2D5AUV13AX API manufacturers, exporters, distributors and traders.
UNII-2D5AUV13AX Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of UNII-2D5AUV13AX GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right UNII-2D5AUV13AX GMP manufacturer or UNII-2D5AUV13AX GMP API supplier for your needs.
A UNII-2D5AUV13AX CoA (Certificate of Analysis) is a formal document that attests to UNII-2D5AUV13AX's compliance with UNII-2D5AUV13AX specifications and serves as a tool for batch-level quality control.
UNII-2D5AUV13AX CoA mostly includes findings from lab analyses of a specific batch. For each UNII-2D5AUV13AX CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
UNII-2D5AUV13AX may be tested according to a variety of international standards, such as European Pharmacopoeia (UNII-2D5AUV13AX EP), UNII-2D5AUV13AX JP (Japanese Pharmacopeia) and the US Pharmacopoeia (UNII-2D5AUV13AX USP).
LOOKING FOR A SUPPLIER?
